| RS202145681 |
MSH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS202145941 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, FH-related disorder |
| RS202146097 |
COL4A6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202146344 |
PGAP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS202147112 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome |
| RS202147495 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Pituitary adenoma 5 |
| RS202147607 |
FECH
|
Health Risk |
Pathogenic/Likely pathogenic |
Protoporphyria, erythropoietic |
| RS202148411 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, MYO15A-related disorder |
| RS202148693 |
CYP4V2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bietti crystalline corneoretinal dystrophy, Corneal dystrophy |
| RS202148793 |
LGI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial temporal lobe |
| RS202148801 |
CR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202148932 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS202148971 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS202148988 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |
| RS202149382 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS202149403 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 6, Nephronophthisis |
| RS202149526 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, TBCD-related disorder |
| RS202149647 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 7, Nephronophthisis 8 |
| RS202149761 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, 6 conditions |
| RS202149931 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS202149945 |
SBF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4B3, Charcot-Marie-Tooth disease type 4B3 |
| RS202149985 |
TH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive DOPA responsive dystonia, TH-related disorder |
| RS202150225 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, Androgen resistance syndrome |
| RS202150325 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 6 |
| RS202150793 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Retinal dystrophy |
| RS202150912 |
ABHD12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202150959 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS202151337 |
SCN8A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS202151375 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Inborn genetic diseases |
| RS202151522 |
PALB2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS202152511 |
SCN9A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS202152674 |
CACNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS202152952 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontometaphyseal dysplasia, Heterotopia |
| RS202153052 |
ALPK3
|
Health Risk |
Pathogenic |
— |
| RS202153130 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS202153520 |
COL9A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epiphyseal dysplasia, multiple |
| RS202153611 |
EXT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Exostoses, multiple |
| RS202153689 |
MTHFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS202153947 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS202154006 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant keratitis, 11p partial monosomy syndrome |
| RS202154028 |
GANAB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202154504 |
RPGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS202154759 |
KIDINS220
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, KIDINS220-related disorder |
| RS202155515 |
IFT122
|
Health Risk |
Conflicting classifications of pathogenicity |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS202155613 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS202155679 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate B, Inborn genetic diseases |
| RS202156491 |
SBF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4B3, SBF1-related disorder |
| RS202156673 |
OTOGL
|
Health Risk |
Conflicting classifications of pathogenicity |
OTOGL-related disorder, OTOGL-related disorder |
| RS202156895 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Pituitary adenoma 5 |
| RS202156896 |
ERCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group D |
| RS202157063 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 5 |
| RS202157161 |
MAN1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rafiq syndrome, Rafiq syndrome |
| RS202157455 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS202158511 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type IV |
| RS202158568 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS202158691 |
ADAMTS10
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani syndrome 1, Weill-Marchesani syndrome 1 |
| RS202158738 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RAI1-related disorder |
| RS202158964 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS202158991 |
TRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Trichorhinophalangeal syndrome, type III |
| RS202159067 |
SETD1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, SETD1A-related disorder |
| RS202159463 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS202159627 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, familial restrictive |
| RS202159869 |
ROR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachydactyly type B1, Autosomal recessive Robinow syndrome |
| RS202159934 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS202159946 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Congenital muscular dystrophy due to partial LAMA2 deficiency |
| RS202159966 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Nephronophthisis |
| RS202160072 |
LDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency, Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency |
| RS202160208 |
GMPPB
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14 |
| RS202160275 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Early-onset myopathy with fatal cardiomyopathy |
| RS202160435 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS202160464 |
MMP9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202160739 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS202160755 |
STIM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to STIM1 deficiency, Stormorken syndrome |
| RS202160994 |
CTSC
|
Health Risk |
Pathogenic |
Periodontitis, aggressive 1 |
| RS202161021 |
LEMD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dermatofibrosis lenticularis disseminata, Inborn genetic diseases |
| RS202161397 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, KCNMA1-related disorder |
| RS202161551 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS202161592 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS202161781 |
PIGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Inborn genetic diseases |
| RS202161790 |
PEX16
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 8A (Zellweger), Peroxisome biogenesis disorder |
| RS202161810 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, Inborn genetic diseases |
| RS202162034 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Seckel syndrome 1, Inborn genetic diseases |
| RS202162088 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia 49, Monosomy 7 myelodysplasia and leukemia syndrome 1 |
| RS202162247 |
KCNK4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202162496 |
FSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian dysgenesis 1, Ovarian hyperstimulation syndrome |
| RS202162520 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myoclonic epilepsy, Self-limited epilepsy with centrotemporal spikes |
| RS202164262 |
DDHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 28, Hereditary spastic paraplegia |
| RS202164519 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Inborn genetic diseases |
| RS202164814 |
ARMC9
|
Health Risk |
Conflicting classifications of pathogenicity |
ARMC9-related disorder, ARMC9-related disorder |
| RS202165247 |
ARSG
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202166023 |
LRSAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease |
| RS202166083 |
PCARE
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS202166096 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS202166176 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS202166253 |
THPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocythemia 1, Thrombocythemia 1 |
| RS202166344 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fumarase deficiency |
| RS202166561 |
ACAN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202166715 |
SLC5A1
|
Health Risk |
Pathogenic |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS202166889 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS202167077 |
ECEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
ECEL1-related disorder, Inborn genetic diseases |